Zoll’s RescueNet 12-Lead is a free and versatile transmission system that allows healthcare providers to receive and manage 12-lead ECGs from just about anywhere. It is browser based for maximum flexibility and universal access. RescueNet 12-lead data can be accessed via e-mail, fax, computer, tablet, or handheld simultaneously. The system is safe and effective for hospitals.  All information is encrypted and password protected, and supports customer compliance requirements with HIPAA and HITECH. All 12-leads are archived in the cloud and system activity reports provide information to manage workflow.

 

Stemi lesion as seen on angiography

A recent review of data from the CathPCI Registry, part of the American College of Cardiology’s (ACC) National Cardiovascular Data Registry (NCDR), offers some insight into average, real-world D2B times.[1] For STEMI patients who arrived at an angioplasty-capable hospital, the average time from hospital arrival to treatment was 64.5 minutes. For patients requiring transfer to another hospital, the average time from arrival at the first hospital to treatment was 121 minutes.  

 
STEMI, ECG, remote access, airstrip

Time is critical for the thousands of patients that suffer from an ST-elevation myocardial infarction (STEMI) each year. Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that a hospital’s door-to-balloon (D2B) times for STEMI patients be 90 minutes or less, starting from the moment patients enter the emergency department (ED) to the second a percutaneous coronary intervention (PCI) is performed. Hospitals with catherization laboratories are using a range of methods, varying from the use of advanced technologies to the implementation of certain protocols, to meet this target and shave off their D2B times.
The economic benefits of radial, transradial access for PCI coronary interventions
radial access

There has been much discussion about how use of transradial access may help reduce costs by cutting hospital admissions, length of stay and observation periods, while also reducing bleeding complications and the need for transfusions. Few centers could offer hard numbers showing these savings, however empirical evidence is now surfacing that these statements are true. The numbers show that transradial programs are impacting several hospitals’ bottom lines. 

 

Agfa HealthCare's stated core belief is centered around helping imaging providers succeed, yet a majority of U.S. clients interviewed by KLAS report gaps in reaching desired results when using Agfa as a vendor. The reasons and other details can be found in the new KLAS vendor-specific report Agfa HealthCare Study 2013: Partnering with Agfa in 2013.

Fujifilm Medical Systems U.S.A. Inc. launched the Synapse Vendor Neutral Archive (VNA) into its informatics portfolio. The technology will enable customers to manage all types of data generated within their healthcare institution. Instead of the data being standards or non-standards based, Synapse VNA technology will catalog and maintain the data in a patient centric model allowing a single access point for EMRs and other systems.

TeraRecon highlighted the broad capability of its flagship iNtuition enterprise image management solution to support enterprise-wide vendor-neutral viewing of medical images, at the annual meeting of the Healthcare Information and Management Systems Society, (HIMSS), March 4-6, 2013.


 

Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with Comecer SPA. Through this agreement, Bayer and Comecer are providing customers with an integrated nuclear medicine solution – combining the clinical administration capabilities of Intego with the Comecer's protection technologies for PET/CT centers around the world.

 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now